Circulating levels of GDF-15 and calprotectin for prediction of in-hospital mortality in COVID-19 patients: A case series

Luis García de Guadiana Romualdo, María Dolores Rodríguez Mulero, Marta Hernández Olivo, Carlos Rodríguez Rojas, Verónica Ramos Arenas, Mercedes González Morales, Ana Blazquez Abellán, Pablo Conesa-Zamora, Josefina García-García, Andrés Conesa Hernández, Daniel Morell-García, María Dolores Albaladejo-Otón, Luciano Consuegra-Sánchez, Luis García de Guadiana Romualdo, María Dolores Rodríguez Mulero, Marta Hernández Olivo, Carlos Rodríguez Rojas, Verónica Ramos Arenas, Mercedes González Morales, Ana Blazquez Abellán, Pablo Conesa-Zamora, Josefina García-García, Andrés Conesa Hernández, Daniel Morell-García, María Dolores Albaladejo-Otón, Luciano Consuegra-Sánchez

No abstract available

Keywords: COVID-19; Calprotectin; GDF-15; Prognosis.

Conflict of interest statement

Declaration of Competing Interest The authors declare no competing interests.

References

    1. Li H., Xiang X., Ren H., Xu L., Zhao L., Chen X. Serum amyloid a is a biomarker of severe coronavirus disease and poor prognosis. J Infect. 2020;80:646–655.
    1. Lin Z., Long F., Yang Y., Chen X., Xu L., Yang M. Serum ferritin as an independent risk factor for severity in COVID-19 patients [published online ahead of print. J Infect. 2020 Jun 24. 2020;S0163-4453(20)30434-5.
    1. Merad M., Martin J.C. Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol. 2020;20:355–362.
    1. Tay M.Z., Poh C.M., Rénia L., MacAry P.A., Ng L.F.P. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20:363–374.
    1. Bohn M.K., Lippi G., Horvath A., Sethi S., Koch D., Ferrari M. Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence. Clin Chem Lab Med. 2020;58:1037–1052.
    1. Pruenster M., Vogl T., Roth J., Sperandio M. S100A8/A9: from basic science to clinical application. Pharmacol Ther. 2016;167:120–131.
    1. Wischhusen J., Melero I., Fridman W.H. Growth differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint. Front Immunol. 2020;11:951.
    1. Wang S., Song R., Wang Z., Jing Z., Wang S., Ma J. S100A8/A9 in inflammation. Front Immunol. 2018;9:1298.
    1. Shi H, Zuo Y, Yalavarthi S, Gockman K, Zuo M, Madison JA, et al. Neutrophil calprotectin identifies severe pulmonary disease in COVID-19. Preprint. medRxiv. 2020;2020.05.06.20093070. Published 2020 May 10. doi:10.1101/2020.05.06.20093070.
    1. Wu Q., Jiang D., Schaefer N.R., Harmacek L., O´Connor B.P., Eling T.E. Overproduction of growth differentiation factor 15 promotes human rhinovirus infection and virus-induced inflammation in the lung. Am J Physiol Lung Cell Mol Physiol. 2018;314:L514–L527.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe